Guro F. Giskeødegård
Bakgrunn og aktiviteter
Guro Fanneløb Giskeødegård has a PhD in Medical Technology, and is currently working as a researcher at the MR Cancer group. Her research is focused on MR spectroscopy of tissue samples and biofluids from breast and prostate cancer patients, and she has a special focus on multivariate data analysis of the MR spectra. The research goal is to identify biomarkers for improved diagnosis and treatment of breast and prostate cancer.
Vitenskapelig, faglig og kunstnerisk arbeid
Et utvalg av nyere tidsskriftspublikasjoner, kunstneriske produksjoner, bok, inklusiv bokdeler og rapport-del. Se alle publikasjoner i databasen
Tidsskriftspublikasjoner
- (2019) Acetaminophen cytotoxicity in HepG2 cells is associated with a decoupling of glycolysis from the TCA cycle, loss of NADPH production, and suppression of anabolism. Archives of Toxicology. vol. 93 (2).
- (2019) The effect of sampling procedures and day-to-day variations in metabolomics studies of biofluids. Analytica Chimica Acta. vol. 1081.
- (2019) Biomarker discovery using NMR based metabolomics of tissue. Methods in molecular biology. vol. 2037.
- (2019) Serum cytokine patterns in first half of pregnancy. Cytokine. vol. 119.
- (2018) Integrative metabolic and transcriptomic profiling of prostate cancer tissue containing reactive stroma. Scientific Reports. vol. 8:14269.
- (2018) NMR-based metabolomics of biofluids in cancer. NMR in Biomedicine. vol. 32 (10).
- (2018) Metabolite and lipoprotein responses and prediction of weight gain during breast cancer treatment. British Journal of Cancer. vol. 119 (9).
- (2017) Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome. Breast Cancer Research. vol. 19.
- (2017) Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy. British Journal of Cancer. vol. 117 (11).
- (2017) Combined 18F-Fluciclovine PET/MRI shows potential for detection and characterization of high-risk prostate cancer. Journal of Nuclear Medicine. vol. 59 (5).
- (2017) Evaluation of metabolomic changes during neoadjuvant chemotherapy combined with bevacizumab in breast cancer using MR spectroscopy. Metabolomics. vol. 13:37.
- (2017) Metabolic portraits of breast cancer by HR MAS MR spectroscopy of intact tissue samples. Metabolites. vol. 7 (2:18).
- (2016) Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes. Cancer & Metabolism. vol. 4.
- (2016) Impact of freezing delay time on tissue samples for metabolomic studies. Frontiers in Oncology. vol. 6.
- (2015) Changes to intermediary metabolites in sporadic and LRRK2 Parkinson's disease demonstrated by proton magnetic resonance spectroscopy. Parkinson's Disease. vol. 2015.
- (2015) Preprocessing of NMR metabolomics data. Scandinavian Journal of Clinical and Laboratory Investigation. vol. 75 (3).
- (2015) High-Resolution Magic-Angle-Spinning NMR Spectroscopy of Intact Tissue. Methods in molecular biology. vol. 1277.
- (2015) Diurnal rhythms in the human urine metabolome during sleep and total sleep deprivation. Scientific Reports. vol. 5.
- (2015) Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia. British Journal of Cancer. vol. 113.
- (2014) Metabolic characterization of triple negative breast cancer. BMC Cancer. vol. 14.